Overexpression of Endoglin Modulates TGF-β1-Signalling Pathways in a Novel Immortalized Mouse Hepatic Stellate Cell Line

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Meurer, Steffen K ^a   Alsamman, Muhammad ^a   Sahin, Hacer ^a   Wasmuth, Hermann E ^a   Kisseleva, Tatiana ^b   Brenner, David A ^b   Trautwein, Christian ^a   Weiskirchen, Ralf ^a   Scholten, David ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA ACTIN; COLLAGEN TYPE 1; COMPLEMENTARY DNA; CONNECTIVE TISSUE GROWTH FACTOR; DESMIN; DIFFERENTIATION ANTIGEN; ENDOGLIN; GREEN FLUORESCENT PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OSTEOGENIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; REGULATOR PROTEIN; RNA; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENSITOMETRY; DNA SYNTHESIS; EXTRACELLULAR MATRIX; IN VIVO STUDY; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; STELLATE CELL; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL MARKERS; CELL LINE, TRANSFORMED; COLLAGEN; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLUORESCENCE; GREEN FLUORESCENT PROTEINS; HEPATIC STELLATE CELLS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGANDS; LIVER CIRRHOSIS; MICE; MICE, INBRED C57BL; PROTO-ONCOGENE PROTEINS C-SIS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84874251873     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056116     Document Type: Article

References (50)

1. Bataller R, Brenner DA, (2005) Liver fibrosis. J Clin Invest 115: 209-218.
2. Friedman SL, (2008) Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 88: 125-172.
3. Herrmann J, Gressner AM, Weiskirchen R, (2007) Immortal hepatic stellate cell lines: useful tools to study hepatic stellate cell biology and function? J Cell Mol Med 11: 704-722.
4. Xu L, Hui AY, Albanis E, Arthur MJ, O'Byrne SM, et al. (2005) Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 54: 142-151.
5. Schnabl B, Choi YH, Olsen JC, Hagedorn CH, Brenner DA, (2002) Immortal activated human hepatic stellate cells generated by ectopic telomerase expression. Lab Invest 82: 323-333.
6. Blaner WS, O'Byrne SM, Wongsiriroj N, Kluwe J, D'Ambrosio DM, et al. (2009) Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage. Biochim Biophys Acta 1791: 467-473.
7. Asahina K, Tsai SY, Li P, Ishii M, Maxson RE Jr, et al. (2009) Mesenchymal origin of hepatic stellate cells, submesothelial cells, and perivascular mesenchymal cells during mouse liver development. Hepatology 49: 998-1011.
8. Cao Y, Szabolcs A, Dutta SK, Yaqoob U, Jagavelu K, et al. (2010) Neuropilin-1 mediates divergent R-Smad signaling and the myofibroblast phenotype. J Biol Chem 285: 31840-31848.
9. Wynn T, (2008) Cellular and molecular mechanisms of fibrosis. J Pathol 214: 199-210.
10. Brenner DA, (2009) Molecular pathogenesis of liver fibrosis. Trans Am Clin Climatol Assoc 120: 361-368.
11. Blobe GC, Schiemann WP, Lodish HF, (2000) Role of transforming growth factor beta in human disease. N Engl J Med 342: 1350-1358.
12. Kanzler S, Lohse AW, Keil A, Henninger J, Dienes HP, et al. (1999) TGF-beta1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis. Am J Physiol 276: G1059-1068.
13. Sato M, Muragaki Y, Saika S, Roberts AB, Ooshima A, (2003) Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 112: 1486-1494.
14. Orlova VV, Liu Z, Goumans MJ, ten Dijke P, (2011) Controlling angiogenesis by two unique TGF-beta type I receptor signaling pathways. Histol Histopathol 26: 1219-1230.
15. Uchinami H, Seki E, Brenner DA, D'Armiento J, (2006) Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis. Hepatology 44: 420-429.
16. Shi Y, Massague J, (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700.
17. Gougos A, Letarte M, (1990) Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J Biol Chem 265: 8361-8364.
18. Bernabeu C, Conley BA, Vary CP, (2007) Novel biochemical pathways of endoglin in vascular cell physiology. J Cell Biochem 102: 1375-1388.
19. Guerrero-Esteo M, Lastres P, Letamendia A, Perez-Alvarez MJ, Langa C, et al. (1999) Endoglin overexpression modulates cellular morphology, migration, and adhesion of mouse fibroblasts. Eur J Cell Biol 78: 614-623.
20. Meurer SK, Tihaa L, Lahme B, Gressner AM, Weiskirchen R, (2005) Identification of endoglin in rat hepatic stellate cells: new insights into transforming growth factor beta receptor signaling. J Biol Chem 280: 3078-3087.
21. Velasco S, Alvarez-Munoz P, Pericacho M, Dijke PT, Bernabeu C, et al. (2008) L- and S-endoglin differentially modulate TGFbeta1 signaling mediated by ALK1 and ALK5 in L6E9 myoblasts. J Cell Sci 121: 913-919.
22. Diez-Marques L, Ortega-Velazquez R, Langa C, Rodriguez-Barbero A, Lopez-Novoa JM, et al. (2002) Expression of endoglin in human mesangial cells: modulation of extracellular matrix synthesis. Biochim Biophys Acta 1587: 36-44.
23. Clemente M, Nunez O, Lorente R, Rincon D, Matilla A, et al. (2006) Increased intrahepatic and circulating levels of endoglin, a TGF-beta1 co-receptor, in patients with chronic hepatitis C virus infection: relationship to histological and serum markers of hepatic fibrosis. J Viral Hepat 13: 625-632.
24. Meurer SK, Tihaa L, Borkham-Kamphorst E, Weiskirchen R, (2011) Expression and functional analysis of endoglin in isolated liver cells and its involvement in fibrogenic Smad signalling. Cell Signal 23: 683-699.
25. Yagmur E, Rizk M, Stanzel S, Hellerbrand C, Lammert F, et al. (2007) Elevation of endoglin (CD105) concentrations in serum of patients with liver cirrhosis and carcinoma. Eur J Gastroenterol Hepatol 19: 755-761.
26. Schafer S, Zerbe O, Gressner AM, (1987) The synthesis of proteoglycans in fat-storing cells of rat liver. Hepatology 7: 680-687.
27. Weiskirchen R, Gressner AM, (2005) Isolation and culture of hepatic stellate cells. Methods Mol Med 117: 99-113.
28. Tacke F, Weiskirchen R, (2012) Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques. Expert Rev Gastroenterol Hepatol 6: 67-80.
29. Dennler S, Goumans MJ, ten Dijke P, (2002) Transforming growth factor beta signal transduction. J Leukoc Biol 71: 731-740.
30. Meurer SK, Lahme B, Tihaa L, Weiskirchen R, Gressner AM, (2005) N-acetyl-L-cysteine suppresses TGF-beta signaling at distinct molecular steps: the biochemical and biological efficacy of a multifunctional, antifibrotic drug. Biochem Pharmacol 70: 1026-1034.
31. Cassiman D, van Pelt J, De Vos R, Van Lommel F, Desmet V, et al. (1999) Synaptophysin: A novel marker for human and rat hepatic stellate cells. Am J Pathol 155: 1831-1839.
32. Wasmuth HE, Lammert F, Zaldivar MM, Weiskirchen R, Hellerbrand C, et al. (2009) Antifibrotic Effects of CXCL9 and Its Receptor CXCR3 in Livers of Mice and Humans. Gastroenterology 137: 309-319.e303.
33. Kamada Y, Mori K, Matsumoto H, Kiso S, Yoshida Y, et al. (2012) N-Acetylglucosaminyltransferase V regulates TGF-beta response in hepatic stellate cells and the progression of steatohepatitis. Glycobiology.
34. Dooley S, Delvoux B, Lahme B, Mangasser-Stephan K, Gressner AM, (2000) Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts. Hepatology 31: 1094-1106.
35. Meurer SK, Esser M, Tihaa L, Weiskirchen R, (2012) BMP-7/TGF-beta1 signalling in myoblasts: Components involved in signalling and BMP-7-dependent blockage of TGF-beta-mediated CTGF expression. Eur J Cell Biol 91: 450-463.
36. Scherner O, Meurer SK, Tihaa L, Gressner AM, Weiskirchen R, (2007) Endoglin differentially modulates antagonistic transforming growth factor-beta1 and BMP-7 signaling. J Biol Chem 282: 13934-13943.
37. Borojevic R, Monteiro AN, Vinhas SA, Domont GB, Mourao PA, et al. (1985) Establishment of a continuous cell line from fibrotic schistosomal granulomas in mice livers. In Vitro Cell Dev Biol 21: 382-390.
38. Lee JS, Kang Decker N, Chatterjee S, Yao J, Friedman S, et al. (2005) Mechanisms of nitric oxide interplay with Rho GTPase family members in modulation of actin membrane dynamics in pericytes and fibroblasts. Am J Pathol 166: 1861-1870.
39. Iwaisako K, Brenner DA, Kisseleva T, (2012) What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis. J Gastroenterol Hepatol 27 (Suppl 2): 65-68.
40. Kisseleva T, Brenner DA, (2007) Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis. J Gastroenterol Hepatol 22 (Suppl 1): S73-78.
41. Dudas J, Mansuroglu T, Batusic D, Saile B, Ramadori G, (2007) Thy-1 is an in vivo and in vitro marker of liver myofibroblasts. Cell Tissue Res 329: 503-514.
42. Scholten D, Reichart D, Paik YH, Lindert J, Bhattacharya J, et al. (2011) Migration of fibrocytes in fibrogenic liver injury. Am J Pathol 179: 189-198.
43. Magness ST, Bataller R, Yang L, Brenner DA, (2004) A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations. Hepatology 40: 1151-1159.
44. Jerkic M, Rivas-Elena JV, Santibanez JF, Prieto M, Rodriguez-Barbero A, et al. (2006) Endoglin regulates cyclooxygenase-2 expression and activity. Circ Res 99: 248-256.
45. Wiercinska E, Wickert L, Denecke B, Said HM, Hamzavi J, et al. (2006) Id1 is a critical mediator in TGF-beta-induced transdifferentiation of rat hepatic stellate cells. Hepatology 43: 1032-1041.
46. Schmidt-Weber CB, Letarte M, Kunzmann S, Ruckert B, Bernabeu C, et al. (2005) TGF-{beta} signaling of human T cells is modulated by the ancillary TGF-{beta} receptor endoglin. Int Immunol 17: 921-930.
47. Rodriguez-Barbero A, Obreo J, Alvarez-Munoz P, Pandiella A, Bernabeu C, et al. (2006) Endoglin modulation of TGF-beta1-induced collagen synthesis is dependent on ERK1/2 MAPK activation. Cell Physiol Biochem 18: 135-142.
48. Lee NY, Blobe GC, (2007) The interaction of endoglin with beta-arrestin2 regulates transforming growth factor-beta-mediated ERK activation and migration in endothelial cells. J Biol Chem 282: 21507-21517.
49. Santibanez JF, Perez-Gomez E, Fernandez LA, Garrido-Martin EM, Carnero A, et al. (2010) The TGF-beta co-receptor endoglin modulates the expression and transforming potential of H-Ras. Carcinogenesis 31: 2145-2154.
50. Pannu J, Nakerakanti S, Smith E, ten Dijke P, Trojanowska M, (2007) Transforming growth factor-beta receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways. J Biol Chem 282: 10405-10413.